Stocks in Focus: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Intrepid Potash, Inc. (NYSE:IPI), Capstone Turbine Corporation (NASDAQ:CPST), Hatteras Financial Corp. (NYSE:HTS)
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares dropped 2.87% to $19.29. The company announced that it will report its second quarter 2013 financial results on Wednesday, August 7, 2013, before the market opens. Following the announcement, at 8:30 a.m.Eastern Time, company management will host a conference call and webcast discussion of the results and provide a general corporate update.
Intrepid Potash, Inc. (NYSE:IPI) shares dropped 2.81% to $11.78. IPI’s stock was downgraded by investment analysts at Goldman Sachs Group Inc. from a “neutral” rating to a “sell” rating in a note issued to investors on July 30.
Additionally, the company on July 31 reported financial results for the second quarter of 2013. The company posted second quarter net income of $11.3 million, or $0.15 per share, compared with second quarter 2012 net income of $19.0 million, or $0.25 per share. Adjusted net income was $12.7 million, or $0.17 per share, compared with $18.8 million, or $0.25 per share, in the same period of the prior year.
Capstone Turbine Corporation (NASDAQ:CPST) shares dropped 2.72% to $1.43. The company announced that the proxy materials for its 2013 Annual Meeting of Stockholders have been filed with the United States Securities and Exchange Commission (the “SEC”) and are now available online pursuant to the Notice and Access Rule of the SEC by going to the Company’s web site,www.capstoneturbine.com, and following the “Investor Relations” link. Capstone’s stockholders may obtain hard copies of the proxy materials (including the Annual Report to Stockholders) free of charge by following the instructions in the “Notice of Internet Availability of Proxy Materials” mailed to Capstone’s stockholders on July 16, 2013.
Hatteras Financial Corp. (NYSE:HTS) shares declined 2.69% to $19.18. The company on July 23 announced financial results for the quarter ended June 30, 2013. During the quarter ended June 30, 2013, the Company earned net income available to common shareholders of $65.3 million, or $0.66 per diluted common share, compared to net income of $61.8 million, or $0.62 per diluted common share, during the quarter ended March 31, 2013.
Net interest income for the quarter ended June 30, 2013 was $63.4 million, compared to $71.4 million for the quarter ended March 31, 2013 reflecting the decreasing yield on the portfolio.